ISPOR - PCR166 Real-World Discontinuation of High-Efficacy Disease Modifying Therapies for the Treatment of Multiple Sclerosis: A Targeted Literature Review

PCR166 Real-World Discontinuation of High-Efficacy Disease Modifying Therapies for the Treatment of Multiple Sclerosis: A Targeted Literature Review

Abstract

Authors

A Miller D Veenstra A Bansal

Full Text Cite This Article

Back to Volume 27, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now